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Small, rapidly dividing pluripotent stem cells (PSCs) have unique energetic and biosynthetic demands
compared with typically larger, quiescent differentiated cells. Shifts between glycolysis and oxidative phos-
phorylation with PSC differentiation or reprogramming to pluripotency are accompanied by changes in cell
cycle, biomass, metabolite levels, and redox state. PSC and cancer cell metabolism are overtly similar,
with metabolite levels influencing epigenetic/genetic programs. Here, we discuss the emerging roles for
metabolism in PSC self-renewal, differentiation, and reprogramming.Introduction
Pluripotent stem cells (PSCs), including embryonic stem cells
(ESCs) and induced pluripotent stem cells (iPSCs), have an
unlimited capacity for self-renewal and can differentiate into
every cell type in our bodies, which holds significant promise
for applications in regenerative medicine. Cellular features of
‘‘stemness’’ and underlying genetic and epigenetic mechanisms
that control self-renewal, differentiation, and reprogramming are
being intensely studied (Boyer et al., 2005; Orkin and Hochedlin-
ger, 2011). Rapidly increasing attention is also being directed
toward the roles for metabolism in PSCs. In contrast to differen-
tiated cells, PSCs have a short G1 phase of the cell cycle, during
which most biomass accumulation and differentiation occurs,
limiting PSC growth and differentiation potential (Singh and
Dalton, 2009; Wang et al., 2008). To facilitate rapid cell duplica-
tion, PSCs must balance energetic with biosynthetic demands,
a feature shared with highly proliferative cancer cells. In general,
ATP is produced by glycolysis and oxidative phosphorylation
(OXPHOS), while the synthesis of lipids, nucleotides, and
proteins requires nutrient uptake, processing, and internal
metabolite precursor entry into multiple anabolic pathways
(DeBerardinis et al., 2008). Key differences in metabolism
between PSCs and differentiated cells exist, in contrast to
striking similarities in metabolism between PSCs and cancer
cells. Metabolism in highly proliferative cancer cells directly influ-
ences chromatin organization and transcription (Dang, 2012;
Ward and Thompson, 2012), which likely also occurs in PSCs
to control physiology and fate. Here, to accompany the Perspec-
tive in this issue of Cell Stem Cell by Folmes et al. (2012), we
provide a perspective on the current state of PSC metabolism,which includes consideration of energetics, multiple nutrient
and carbon sources, and oxidation-reduction (redox) states in
the context of early mammalian development, adult-type stem
cells, and cancer. We also examine emerging links between
selected signal transduction pathways, PSC metabolism, and
genetic and epigenetic regulatory networks. Of note, the modest
available data from studies ofmetabolism in PSCs contrasts with
extensive studies in cancer, which has led to gap-filling assump-
tions for PSCs based on similar studies in cancer that should be
interpreted carefully.
Energetics of Pluripotency
OXPHOS can theoretically generate up to 38 mol ATP per mol
glucose (depending on NADH shuttling into mitochondria and
electron transport chain [ETC] coupling efficiency), whereas
glycolysis generates only 2 mol ATP per mol glucose. Yet,
numerous studies show that mouse and human ESCs and iPSCs
have an elevated dependence on glycolysis under aerobic
conditions compared to highly respiring (e.g., cardiomyocytes)
or lowly respiring (e.g., fibroblasts) differentiated cell types
(Chung et al., 2007; Folmes et al., 2011; Panopoulos et al.,
2012; Prigione et al., 2010; Varum et al., 2011; Zhang et al.,
2011). In cancer, a high glycolytic flux provides sufficient ATP
and anabolic precursors for rapid proliferation, with the pentose
phosphate pathway generating ribose-5-phosphate for nucleo-
tides and NADPH-reducing power for nucleotide and lipid
biosynthesis (DeBerardinis et al., 2008; Locasale and Cantley,
2011). Human PSCs also have a high glycolytic flux (Prigione
et al., 2010) and mouse ESCs require increased pentose phos-
phate pathway activity for survival during oxidative stress andCell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc. 589
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Figure 1. Key Differences in Metabolism
between PSCs and Differentiated Cells
Energy metabolism shifts from glycolysis to
OXPHOS with differentiation, or from OXPHOS to
glycolysis with reprogramming to pluripotency.
Glycolytic flux is elevated in PSCs (left panel) to
provide ATP and intermediate metabolites through
the pentose phosphate pathway for nucleotide
and lipid biosynthesis. Glycolysis regulating
enzymes, such as lactate dehydrogenase and
hexokinase, are highly expressed in PSCs, which
also consume oxygen through a functional elec-
tron transport chain. PSCs rely more on glycolysis
for energy because respiration is lower and less
coupled to energy production than in differentiated
cells. Pyruvate entry intomitochondria is limited by
an inactive pyruvate dehydrogenase complex or
by high expression of uncoupling protein 2. The
mitochondrial membrane potential is partially
maintained by hydrolysis of ATP in the complex V
ATP synthase. Less reactive oxygen species is
present in PSCs from lower respiration and
elevated antioxidant enzymes. These features
establish a reduced cellular redox environment
(blue text) that becomes more oxidative (orange
text) with differentiation. The tricarboxylic acid
cycle in PSCs provides intermediate metabolites
such as citrate and a-ketoglutarate that are
siphoned for lipid and amino acid biosynthesis.
ETC, electron transport chain; FA, fatty acid; G-6-
P: glucose-6-phosphate; GSH; glutathione; GSSG, glutathione disulfide; mtDNA, mitochondrial DNA; NAD: nicotinamide adenine dinucleotide; NADP: nico-
tinamide adenine dinucleotide phosphate; PPP, pentose phosphate pathway; R-5-P, ribose-5-phosphate; ROS, reactive oxygen species; TCA, tricarboxylic acid
cycle. Elevated metabolic pathways are indicated with bold letters and arrows.
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Carbon tracing studies show that human ESCs obtain 70%
of their ribose from added glucose, with genes in the pentose
phosphate and lipid biosynthesis pathways highly expressed
before ESC differentiation (Varum et al., 2011; Zhang et al.,
2011). Thus, aerobic glycolysis is a common feature of PSC
and cancer cell metabolism in culture (Figure 1) (Dang, 2012;
Warburg, 1956; Ward and Thompson, 2012).
During PSC differentiation, energy production shifts to the
mitochondrion, a double-membrane organelle that regulates
cellular levels of ATP and intermediate metabolites, Fe-S cluster
and heme biosynthesis, free radical production, Ca2+ homeo-
stasis, and apoptosis through the release of proapoptotic and
antiapoptotic proteins. Studies of mitochondrial morphology
and DNA (mtDNA) levels suggested that ESCs contain fewer
and less mature mitochondria than differentiated cells (Prigione
et al., 2010). However, PSCs are small and the mitochondrial
to total protein mass ratio for PSCs is similar to that measured
for fibroblasts (Birket et al., 2011; Zhang et al., 2011). mtDNA
encodes for only 13 OXPHOS protein subunits out of the more
than 1,500 proteins imported into mitochondria, and genome
copy number alone may not indicate PSC mitochondrial mass
or respiratory function (Zhou et al., 2012). ETC complexes I
through V are assembled in PSCs and oxygen is consumed at
a level similar to that measured for fibroblasts. However, respira-
tion and energy production are less coupled in human PSCs
compared to fibroblasts, consistent with a high glycolytic flux
for energy generation (Shyh-Chang et al., 2011; Zhang et al.,
2011; Zhou et al., 2012). A similar mitochondrial decoupling, or
increased expression of uncoupling proteins, has been reported
in some cancers as well (Ayyasamy et al., 2011; Samudio et al.,
2009). Reduced ETC coupling lessens the production of reactive590 Cell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc.oxygen species (ROS), which suppresses PSC differentiation
and decreases the potential for genome damage (Crespo
et al., 2010; Saretzki et al., 2008; Zhang et al., 2011).
In cancer cells and PSCs citrate, a-ketoglutarate, and other
intermediate metabolites for lipid and amino acid biosynthesis
are siphoned from the TCA cycle to support rapid cell prolifera-
tion (DeBerardinis et al., 2008; Locasale and Cantley, 2011; Pan-
opoulos et al., 2012; Dang, 2012; Ward and Thompson, 2012).
Substrate oxidation results in transfer of a proton and electrons
to NAD+, generating NADH. To restore the NAD+ pool and main-
tain TCA cycle flux requires NADH oxidation through the ETC,
with electrons ultimately donated to oxygen (Figure 1). Respira-
tion is at or near maximum capacity for human PSCs, in contrast
to fibroblasts, which have a large, untapped respiratory reserve
capacity (Folmes et al., 2011; Zhang et al., 2011; Zhou et al.,
2012). Low expression of ETC complex IV cytochrome c oxidase
(COX) subunits, which donate electrons to oxygen,may help limit
the maximum human PSC respiration capacity (Zhou et al.,
2012), which is a distinguishing feature from cancer cell metab-
olism (Dang, 2012; Ward and Thompson, 2012).
Molecular mechanisms that regulate energy metabolism in
PSCs and the changes that occur during differentiation or re-
programming are just being discovered. Glycolysis-regulating
enzymes including hexokinase and lactate dehydrogenase are
highly expressed in PSCs and could be controlled by mTOR
and PI3K signaling pathways that regulate glycolytic genes in
other cell contexts. Glycolytic and OXPHOS pathway gene
expression and DNAmethylation patterns also change during re-
programming to pluripotency (Panopoulos et al., 2012). Several
candidate mechanisms for limiting respiration or ATP production
(in addition to low COX subunit expression) in PSCmitochondria
have been reported. Pyruvate entry into mitochondria is limited
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the expression of uncoupling protein 2 (UCP2) (Shyh-Chang
et al., 2011; Varum et al., 2011; Zhang et al., 2011). Similar
mechanisms have also been reported in cancer. Pyruvate
conversion to acetyl-CoA by PDH and entry into mitochondria
is blocked in hypoxic cancer cells by hypoxia inducible factor
1a (HIF1a)-induced pyruvate dehydrogenase kinase 1 (PDK1)
expression and the inactivation of PDH phosphorylation (Ayyas-
amy et al., 2011; Kim et al., 2006). Also, several types of cancer
re-express UCP2 (Ayyasamy et al., 2011; Kim et al., 2006). An
open mitochondrial permeability transition pore correlates with
reduced respiratory coupling in developing cardiomyocytes,
and pore closure with further differentiation may increase
coupling and mitochondrial ATP production (Hom et al., 2011).
A high ratio of inhibitory factor-1 to the b1 subunit of the ETC
complex V ATP synthase drives the hydrolysis and consumption
of glycolytic ATP at complex V to maintain the mitochondrial
membrane potential and block apoptosis in PSCs (Zhang
et al., 2011). In cancer, ATP concentrations are also lowered
by increased ATP consumption at the endoplasmic reticulum
and by a switch in pyruvate kinase isoforms from M1 to M2
with alternative processing of phosphoenolpyruvate to pyruvate
without the generation of ATP (Fang et al., 2010; Israelsen and
Vander Heiden, 2010; Locasale and Cantley, 2011). All of these
mechanisms limit energy production by OXPHOS in PSCs or
early differentiating cells in preference to glycolysis and its
biosynthetic pathway branches, such as the pentose phosphate
pathway. An interesting question is how genes that control
metabolism are regulated by core pluripotency transcription
factors in PSCs with differentiation or, conversely, during re-
programming.
In Vivo Correlates for PSC Energetics
In mice, one-cell zygotes favor OXPHOS over glycolysis with
pyruvate as the preferred carbon source, which is likely a contin-
uation of oocyte metabolism of stored pyruvate before fertiliza-
tion (Johnson et al., 2003). Morulae (E2.0) increase glucose
uptake and anaerobic glycolysis with upregulation of glucose
transporter and hexokinase gene expression. Blastocysts
(E3.0) further increase anaerobic glycolysis of glucose for
continued rapid cell duplication. Following implantation (E6.0),
anaerobic glycolysis is maximal and gradually shifts to OXPHOS
with germ layer differentiation, similar to in vitro PSC differentia-
tion. Therefore, metabolism in cultured mouse PSCs should
reflect derivation from specific embryonic stages. Mouse ESCs
(mESCs) originate from the inner cell mass of preimplantation
blastocysts, whereas mouse epiblast stem cells (mEpiSCs)
derive from the postimplantation epiblast and represent a later
stage of pluripotency with distinct epigenetic and genetic
features (Nichols and Smith, 2009). The pluripotent state of
human ESCs, even though derived from the inner cell mass,
resembles mEpiSCs more than mESCs. Consistent with the
concept of an embryonic stage-specific metabolism, mEpiSCs
(and human ESCs) are also more dependent on glycolysis than
OXPHOS for energy compared to mESCs (Zhou et al., 2012).
Stabilized expression of HIF1a appears sufficient to advance
mESCs to a mEpiSC-like stage, at least by biomarker patterns
and colony morphology, although a global epigenetic profile
comparison would be beneficial (Zhou et al., 2012). A potentialmechanism for this advancement is by HIF1a repression of
COX subunits in ETC complex IV, with partial loss of respiratory
capacity and concurrent induction of the mEpiSC glycolytic
program. It is unknown whether human PSCs ever assume
a metabolic program that resembles mESCs. Understandably,
this latter issue is complicated by limitations on studies of early
human embryogenesis.
Resetting Metabolism by Nuclear Reprogramming
Somatic cells reprogrammed to pluripotency should become
dependent on glycolysis. Consistent with this prediction,
defined-factor reprogrammed human iPSCs show a high glyco-
lytic carbon flux and increased decoupling of respiration from
ATP production in mitochondria (Folmes et al., 2011; Panopou-
los et al., 2012; Zhang et al., 2011). Intermediate metabolite
levels, epigenetic modifications, and expression levels of meta-
bolic genes resemble human ESCs, with late passage (>p41)
iPSCs significantly closer to ESC metabolite levels than early
passage (p16) cells (Panopoulos et al., 2012). This progressive
resetting of metabolite levels parallels the progressive changes
seen in global epigenetic modifications and gene expression
with late passage iPSCs over prolonged culture times (Chin
et al., 2009). Reprogramming to pluripotency is also more
efficient the closer the glycolytic and OXPHOS energy metabo-
lism profile of the starting somatic cells are to the pattern seen
in ESCs (Panopoulos et al., 2012). This suggests a type of
‘‘metabolic memory’’ that is similar to the ‘‘epigenetic memory’’
contained within certain differentiated lineages with specific
chromatin modifications that may be partially retained through
the reprogramming process (Kim et al., 2010). One prediction
is that a retained metabolic memory could influence the differen-
tiation potential and function of iPSCs of different cells of origin.
Metabolic reprogramming may provide a barrier that must be
overcome to enhance reprogramming efficiency.
Several studies show that metabolism regulates reprogram-
ming efficiency and that metabolic resetting is an active process
during reprogramming. Manipulations that inhibit glycolysis,
such as incubation of somatic cells with 2-deoxyglucose to
compete for glucose uptake, 3-bromopyruvic acid to block
hexokinase 2, or dichloroacetate to impair PDK1, all reduce re-
programming efficiency, whereas augmenting glycolysis with
D-fructose-6-phosphate or by PDK1 activation enhances iPSC
reprogramming efficiency (Folmes et al., 2011; Panopoulos
et al., 2012; Zhu et al., 2010). During the reprogramming process
an increase in the expression of specific glycolytic genes
precedes the gain of expression in genes that regulate self-
renewal, suggesting that metabolic resetting has an early, active
role in the return to pluripotency (Folmes et al., 2011). Interest-
ingly, some reprogramming factors directly regulatemetabolism.
For example, c-Myc promotes glycolysis and represses respira-
tion and Lin28 has been recently shown to stimulate glucose
metabolism (Figure 2) (Zhu et al., 2011). The addition of Lin28
to the reprogramming factor cocktail accelerates the reacquisi-
tion of pluripotency in a proliferation-dependent manner, poten-
tially by enhancing glycolysis (Hanna et al., 2009). However, the
absence of either c-Myc or Lin28 does not block metabolic
resetting in successfully reprogrammed somatic cells (Folmes
et al., 2011), suggesting that this process is a property of plurip-
otency that can be achieved independent of these factors.Cell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc. 591
Figure 2. Metabolic, Signaling, Genetic, and
Epigenetic Network Crosstalk
Glucose enters glycolysis (orange panel) and is
metabolized to lactate. The expression and
activity of glycolytic regulating enzymes are
controlled by mTOR and PI3K signaling pathways
(crosstalk). Reprogramming factors c-Myc and
Lin28 promote glucose metabolism and c-Myc
also suppresses respiration (crosstalk). Alterna-
tively, pyruvate can be converted into two mole-
cules of acetyl-CoA and enter the TCA cycle.
Acetyl-CoA can traffic to the nucleus as a
substrate for acetyltransferase enzymes (cross-
talk). TCA cycle intermediates can be siphoned
into amino acid or lipid biosynthesis pathways,
or can participate in the control of gene expres-
sion. For example, a-ketoglutarate (a-KG) is
a cofactor for Jumonji-domain containing histone
demethylases (crosstalk). Methionine adenosyl-
transferase, an enzyme in amino acid biosyn-
thesis, also converts methionine and ATP into
S-adenosylmethionine (SAM) for DNA methyl-
transferases and other transmethylation reactions
(crosstalk). The NAD+/NADH ratio reflects cellular
redox state and regulates deacetylase enzymes
such as the Sirtuins (crosstalk). Reactive oxygen
species (ROS) are required for lineage-specific
differentiation and are regulated by the p38 MAPK
stress signaling pathway (crosstalk). Lipid bio-
synthesis supports membrane formation but also
provides signaling molecules, including arach-
idonic acid (AA) and docosahexanoic acid (DHA)
(crosstalk). All together, metabolites, the redox
environment, and metabolism-regulated signaling
cascades communicate with the nucleus (gray panel) to directly impact chromatin structure and gene expression programs that may control PSC self-renewal,
differentiation, and reprogramming. Blue buttons indicate nucleus and signaling control of metabolic pathways; orange buttons indicate metabolic pathways that
influence gene expression changes within the nucleus.
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Cellular redox states are regulated by metabolic activities and
impact many biological processes. In some settings, such as
dividing glial precursor cells, the redox state modulates the
balance between self-renewal versus differentiation (Smith
et al., 2000). ROS is minimized in PSCs by a reduction in
substrate oxidation and respiratory coupling, and by the
elevated expression of antioxidant stress genes UCP2, SOD2,
and GPX2, which are repressed with the induction of differentia-
tion (Saretzki et al., 2008; Zhang et al., 2011). Increased ROS
promotes lineage-specific differentiation, which for cardiomyo-
cyte precursors is through the induced activity of the p38
MAPK stress signaling pathway (Figure 2) (Crespo et al., 2010).
By contrast, increased ROS promotes cell proliferation and not
the differentiation of cancer cells (Weinberg et al., 2010). The
underlying mechanisms for this differential response to ROS in
distinct cellular contexts are unknown. During mESC differentia-
tion, the ratio of reduced to oxidized glutathione decreases as
does the level of NADH, and the unsaturated metabolome with
carbon-carbon double bonds is replaced by an oxidativemetab-
olome, effectively increasing the overall cellular oxidation state
(Wang et al., 2009; Yanes et al., 2010). Blocking the oxidative
eicosanoid signaling cascade in ESCs can also delay differenti-
ation (Yanes et al., 2010). Tight regulation of specific redox
species, such as the NAD+/NADH ratio, is critical for signaling
events that require NAD+-dependent deacetylase activities
(Han et al., 2008). An important unexplored question is how
changes in PSC metabolism influence the cellular redox state
to regulate signal transduction and cell fate. Since the NAD+/592 Cell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc.NADH ratio is regulated by glycolytic andmitochondrial activities
that change dramatically during differentiation or reprogramming
(Locasale and Cantley, 2011), the NAD+/NADH redox state may
have a role in driving PSC fate.
Amino Acid and Lipid Metabolism
Proliferating cells use glucose and anapleurotic, or replenish-
ing, fuels such as glutamine to supply the TCA cycle and
generate energy and intermediate metabolites for biosynthetic
reactions (Vander Heiden et al., 2009). The recently discovered
mitochondrial pyruvate transporter may provide a pathway to
the TCA cycle for PSCs and early differentiating cells (Divakar-
uni and Murphy, 2012). As expected, amino acids and fatty
acids are also required for PSC self-renewal and differentiation.
An amino acid ‘‘drop-out’’ study showed that mESCs and
embryos, but not fibroblasts, require the catabolism of threo-
nine for survival (Wang et al., 2009). Whole metabolome studies
showed that threonine provides glycine through one-carbon
metabolism for purine biosynthesis to support rapid DNA repli-
cation in mESCs, which is not required for slower proliferating
fibroblasts. Threonine dehydrogenase (TDH), which catalyzes
the initial rate-limiting step in threonine catabolism, is highly ex-
pressed in mESCs and disappears with lineage nonspecific
differentiation to embryoid bodies. Metabolomic data also indi-
cate that purine nucleotides are differentially present between
human ESCs and somatic cells (Panopoulos et al., 2012),
although a gene encoding a functional human TDH enzyme is
lacking, being replaced by a pseudogene with three nonfunc-
tional mutations. It will be interesting to determine how human
Cell Stem Cell
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TDH enzyme.
Lipids are essential components of plasma and organelle
membranes, and fatty acids arising by de novo synthesis or liber-
ated from stored fat can function as secondary messengers for
specific signal transduction pathways. Lipids that participate in
signaling cascades, such as arachidonic acid, diacylglycerol,
and prostaglandins, are among the most highly expressed
metabolites in PSCs (Yanes et al., 2010). How these messenger
lipids affect PSC fate decisions and how their levels are regu-
lated are interesting questions, especially when considering their
identified signaling roles in cancer. For example, monoacylgly-
cerol lipase regulates a fatty acid network enriched in oncogenic
signaling lipids, such as prostaglandins, that promotes tumor
aggressiveness, such as cell motion and metastasis (Nomura
et al., 2010). It would be interesting to determine whether lipid
metabolites influence PSC survival, movement, or differentiation
potential and, conversely, reprogramming efficiency. Also, free
fatty acids can provide energy when glucose availability is
restricted, and fatty acid oxidation supports mouse blastocyst
inner cell mass growth and themaintenance of ESC lipid homeo-
stasis (Dunning et al., 2010; Zaugg et al., 2011). Disruption of
carnitine palmitoyltransferase, the rate-limiting enzyme for fatty
acid oxidation, leads to ATP depletion and to decreased resis-
tance to nutrient deprivation, indicating a key role for fatty acids
in mESC energy generation (Zaugg et al., 2011).
Adult-Type Stem Cells and the Environment
Similar to PSCs, hematopoietic stem cells (HSCs) consume fatty
acids but probably rely mainly on glycolysis and increase
OXPHOS upon differentiation (Figure 1) (Ito et al., 2012; Suda
et al., 2011). However, unlike PSCs or their more differentiated
multipotent progenitor cells, HSCs are quiescent and cycle
slowly, indicating that a high cell replication rate is not required
to favor glycolyticmetabolism. This fundamental differencemight
reflect an HSC adaptation to a bone marrow niche with limited
oxygen perfusion (Suda et al., 2011). One potential advantage
of this difference is reduced ROS production. HSCs are sensitive
to ROS, and they either die or differentiate with excessive ROS.
With physiologic demand HSCs differentiate, which increases
OXPHOS and ROS production as progenitors are recruited
away from the hypoxic stem cell niche for functions in the animal
periphery. Therefore, the higher level of glycolysis in HSCs rela-
tive to their multipotent progenitors may reflect an adaptive
strategy to compensate for reduced mitochondrial energy
production in the hypoxic niche that supports HSC self-renewal.
Additional types of adult stem cells reside in hypoxic or nor-
moxic niches. Some of these adult stem cells cycle slowly,
such as skin stem cells in the hair follicle, whereas some cycle
rapidly, such as intestinal crypt stem cells. It will be interesting
to characterize the metabolic state of these stem cells to deter-
mine whether the relative dependence on glycolysis versus
OXPHOS is an environmental adaptation strategy or is deter-
mined by intrinsic metabolic demands to maintain stem cell
identity. In addition, ESCs originate from a hypoxic preimplanta-
tion blastocyst microenvironment, although they are routinely
grown in ambient oxygen following derivation, and reprog-
rammed iPSCs may never experience hypoxia. Low oxygen
content also helps to maintain ESC self-renewal and increasesiPSC reprogramming efficiency (Wion et al., 2009). Yet, both
ESCs and iPSCs share similar metabolic features. So, for
PSCs, the metabolic program is integrated with stemness inde-
pendent of oxygen availability, whereas certain adult stem cell
types may use different molecular mechanisms for distinct
purposes to arrive at a relative dependence on glycolysis.Outlook: StemCell Metabolism Links to Epigenetics and
Gene Expression
A key unresolved question is how metabolism integrates with
epigenetic and genetic programs to coordinately regulate PSC
function and fate. Metabolite fluxes can be controlled by
enzymes that are regulated by transcription factors including
c-Myc and HIF1a, and by signaling network molecules including
PI3K, AKT, and mTOR (Figure 2) (DeBerardinis et al., 2008).
Downstream studies in mammalian cells have shown that inter-
mediate metabolites can function as substrates or cofactors for
enzymes that regulate chromatin structure and gene expression.
For example, acetyl-CoA generated by catabolism of glucose,
fatty acids, or certain amino acids in mitochondria can be trans-
ported into the cytosol and enter the nucleus to increase histone
acetylation (Cai et al., 2011; Wellen et al., 2009). Similarly,
a-ketoglutarate can exit the mitochondria to function as a
cofactor for dioxygenase enzymes including Jumonji-family his-
tone demethylases, TET-family DNA hydroxylases, and possibly
prolyl hydroxylases that control HIF1a/2a transcription factor
stability (Figure 2) (Xu et al., 2011). Defects in TCAcycle enzymes,
such as succinate dehydrogenase, fumarate hydratase, and iso-
citrate dehydrogenase, cause inherited benign or malignant
tumors by altering DNA and histonemodifications to causewide-
spread transcriptional dysregulation (Nunnari and Suomalainen,
2012). Deacetylase enzymes, such as Sirtuin family proteins, are
sensitive to redox state and can impact histone modifications
and posttranscriptional changes through nonhistone protein
deacetylation (Haigis and Guarente, 2006). The production of
S-adenosylmethionine is tightly linked to amino acid metabolism
and is a donor for DNA methylation with high levels present in
iPSCs (Panopoulos et al., 2012). These and likely additional
metabolites could exert tremendous influence and broad regula-
tory control over the PSC genome. Because cofactors andmodi-
fying enzymes are always present at some level, specificity must
be imparted or all genes would be regulated synchronously,
which is not observed with metabolite dysregulation in cancer.
Therefore, a hierarchy of target chromatin regions and associ-
ated genes, miRNAs, and noncoding elements likely exists,
which could be regulated by enzyme recruitment with DNA-
binding factors, local depletion or excess cofactors, or themodi-
fication of spatial and temporal sublocalization of enzymeswithin
the nucleus (Katada et al., 2012). Links being forged between
metabolismandepigenetics in thedysregulated setting of cancer
provide added impetus for determining how metabolism and
metabolites exert influence over epigenetic and genetic circuits
that establish and maintain PSC self-renewal and differentiation,
or that reestablish pluripotencywith somatic cell reprogramming.ACKNOWLEDGMENTS
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